Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 29, 2021Frontiers in NutritionOpen Access

The Challenges of Designing and Implementing Clinical Trials With Broccoli Sprouts… and Turning Evidence Into Public Health Action

View Full Paper
Ask AI
Bookmark
Share

Authors

JFJed W. FaheyJohns Hopkins University
Thomas W. Kensler
Thomas W. KenslerRutgers, The State University of New Jersey

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fahey et al. (2021) studied this question.

synapsesocial.com/papers/6a8da252dafbba83333158cfhttps://doi.org/10.3389/fnut.2021.648788
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Current Landscape of NRF2 Biomarkers in Clinical Trials2020 · 106 citations
  2. 2Bioavailability of Sulforaphane from Two Broccoli Sprout Beverages: Results of a Short-term, Cross-over Clinical Trial in Qidong, China2011 · 209 citations
  3. 3Effects of Glucosinolate-Rich Broccoli Sprouts on Urinary Levels of Aflatoxin-DNA Adducts and Phenanthrene Tetraols in a Randomized Clinical Trial in He Zuo Township, Qidong, People's Republic of China2005 · 317 citations
  4. 4Phase 1 Study of a Sulforaphane-Containing Broccoli Sprout Homogenate for Sickle Cell Disease2016 · 67 citations
  5. 5Prevention of Carcinogen-Induced Oral Cancer by Sulforaphane2016 · 120 citations